OpenSAFELY papers

Showing 97 published or preprint papers in the OpenSAFELY category.

  1. Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak

    Investigation of the effect of the covid-19 pandemic on the number of patients with group A streptococcal infections and related antibiotic prescriptions

    Status: Published

    Categories

    • OpenSAFELY
  2. OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents

    We conducted a matched sequential trials observational study to assess the safety and effectiveness of first and second dose BNT162b2 COVID-19 vaccination in children and adolescents in England.

    Status: Preprint

    Categories

    • OpenSAFELY
  3. Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults

    Incidence and differences in demographic and clinical characteristics in recorded long COVID in primary care records in England.

    Status: Published

    Categories

    • OpenSAFELY
  4. Impacts of the COVID-19 pandemic on deprivation-level differences in cardiovascular hospitalisations

    To examine the impact of the pandemic on deprivation-related inequalities in hospitalisations for CVD conditions in Denmark and England between March 2018 and December 2021.

    Status: Preprint

    Categories

    • OpenSAFELY
  5. The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism

    COVID-19 lockdowns led to increased reports of depressive symptoms in the general population and impacted the health and social care services of people with learning disability and autism. We explored whether the COVID-19 pandemic had an impact on antidepressant prescribing trends within these and the general population.

    Status: Preprint

    Categories

    • OpenSAFELY
  6. Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

    We aimed to evaluate and estimate the differences in health impacts of long COVID across sociodemographic categories and quantify this in Quality-Adjusted Life-Years (QALYs), widely used measures across health systems.

    Status: Published

    Categories

    • OpenSAFELY
  7. Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data

    Identification of people receiving chronic kidney replacement therapy using primary and secondary care records compared with gold standard registry data.

    Status: Published

    Categories

    • OpenSAFELY
  8. The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate

    This study investigated whether disease-modifying anti-rheumatic drug (DMARD) safety monitoring was affected during the COVID-19 pandemic, with additional focus on effects within key health inequality groups.

    Status: Published

    Categories

    • OpenSAFELY
  9. The impact of COVID-19 on medication reviews in English primary care

    This study investigated whether the rate of medication reviews in primary care were affected during the COVID-19 pandemic, with breakdown by regional, clinical and demographic subgroups.

    Status: Published

    Categories

    • OpenSAFELY
  10. Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England

    A comparison of the Pfizer BA.4-5 and Sanofi vaccines for protecting against Covid-19 during Spring 2023 booster programme in England

    Status: Preprint

    Categories

    • OpenSAFELY
  11. Impact of vaccination on the association of COVID-19 with cardiovascular diseases

    We quantified associations between COVID-19 diagnosis and cardiovascular diseases in different vaccination and variant eras using linked electronic health records for ~40% of the English population.

    Status: Published

    Categories

    • OpenSAFELY
  12. During the COVID-19 pandemic 20 000 prostate cancer diagnoses were missed in England

    This study investigated the effect of the COVID-19 pandemic on prostate cancer incidence, prevalence, and mortality in England. The pandemic led to 20 000 missed prostate cancer diagnoses in England alone.

    Status: Published

    Categories

    • OpenSAFELY
  13. Changes in opioid prescribing during the COVID-19 pandemic in England

    This study described changes in prevalent and new opioid prescribing during the COVID-19 pandemic, overall, among people in care homes, and stratified by demographics.

    Status: Preprint

    Categories

    • OpenSAFELY
  14. The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19

    This proof-of-principle pharmacovigilance study used Electronic Health Record (EHR) data to examine the safety of sotrovimab, paxlovid and molnupiravir in prehospital treatment of Covid-19

    Status: Preprint

    Categories

    • OpenSAFELY
  15. Measuring BMI in 22 million patients in England

    This study describes the use of four derivations of BMI in OpenSAFELY.

    Status: Published

    Categories

    • OpenSAFELY
  16. Weight trends amongst adults with diabetes or hypertension during the COVID-19 pandemic

    Amongst adults living in England with T2D and/or hypertension, rapid pandemic weight gain was more common amongst females, younger adults, those living in more deprived areas, and those with mental health conditions.

    Status: Published

    Categories

    • OpenSAFELY
  17. Safety of direct-acting oral anticoagulant (DOAC) prescribing

    This study aimed to identify the proportion of those prescribed a DOAC with recorded: weight, estimated Glomerular Filtration Rate (eGFR), creatinine, creatinine clearance (CrCl) and atrial fibrillation (AF). In those with recorded AF and CrCl prescribed the study aimed to identify the proportion with a recommended DOAC dose.

    Status: Published

    Categories

    • OpenSAFELY
  18. OpenSAFELY: a platform for analysing electronic health records designed for reproducible research

    This paper describes OpenSAFELY's reproducibility-by-design approach in detail.

    Status: Published

    Categories

    • OpenSAFELY
  19. Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic

    We determine whether periods of disruption were associated with increased ‘avoidable’ hospital admissions and wider social inequalities in England.

    Status: Published

    Categories

    • OpenSAFELY
  20. Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease

    Cohort study investigating whether ursodeoxycholic acid was associated with COVID-19 related hospitalisation and death in people with primary biliary cirrhosis and primary sclerosing cholangitis.

    Status: Preprint

    Categories

    • OpenSAFELY
  21. Impact of COVID-19 on mental illness in vaccinated and unvaccinated people

    This study examined associations of COVID-19 with subsequent mental illness in the pre-vaccination period of the pandemic and for unvaccinated and vaccinated people after vaccination became available.

    Status: Preprint

    Categories

    • OpenSAFELY
  22. Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic

    Germ Defence is an evidence-based interactive website that promotes behaviour change for infection control within households. To maximise the potential of Germ Defence to effectively reduce the spread of COVID-19, the intervention needed to be implemented at scale rapidly.

    Status: Published

    Categories

    • OpenSAFELY
  23. Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic

    We used OpenSAFELY-TPP data to elucidate the association between non-Covid-19 related sepsis and a range of risk factors during the Covid-19 pandemic

    Status: Published

    Categories

    • OpenSAFELY
  24. Consistency, completeness and external validity of ethnicity recording in NHS primary care records

    We describe the completeness and consistency of primary care ethnicity recording in the OpenSAFELY-TPP database, containing linked primary care and hospital records in >25 million patients in England. We also compared the ethnic breakdown in OpenSAFELY-TPP with that of the 2021 UK census.

    Status: Preprint

    Categories

    • OpenSAFELY
  25. Interpreting pathology test result values with comparators (<, >) in Electronic Health Records research

    A short data report about comparators in pathology test results

    Status: Published

    Categories

    • OpenSAFELY
  26. Antibiotics for Common Infections in Primary Care Before, During and after the COVID-19 Pandemic and Extent of Risk-Based Prescribing: Need for Personalised Guidelines

    We assessed the changes in risk-based prescribing behaviours of antibiotics for common infections in primary care during the Covid-19 pandemic

    Status: Preprint

    Categories

    • OpenSAFELY
  27. The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in England

    We studied how antibiotic precribing for common infections in primary changed duding the Covid-19 pandemic and how this may have affected clincial outcomes

    Status: Published

    Categories

    • OpenSAFELY
  28. Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home

    We describe the impact of the the COVID-19 pandemic on antipsychotic prescribing in those with autism, dementia, learning disability, serious mental illness or living in a care home.

    Status: Published

    Categories

    • OpenSAFELY
  29. Fit notes associated with COVID-19 in 24 million patients’ primary care records

    This study quantified the fit note rate in people with documented SARS-CoV-2 infection or COVID-19 diagnosis in 2020, 2021 and 2022 overall, by demographics, and by time since diagnosis. We also used adjusted Cox regression to compare the fit note rate to the general population.

    Status: Preprint

    Categories

    • OpenSAFELY
  30. Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England

    This study evaluated the effectiveness of the 2022 autumn COVID-19 booster campaign in 50 year olds in England using a regression discontinuity design.

    Status: Preprint

    Categories

    • OpenSAFELY
  31. Challenges in Estimating the Effectiveness of 2 Doses of COVID-19 Vaccine Beyond 6 Months in England

    This paper discusses the challenges in estimating long-term (>6 months) vaccine effectiveness in observational data, primarily due to high uptake of a subsequent third vaccine dose.

    Status: Published

    Categories

    • OpenSAFELY
  32. Gout incidence and management during the COVID-19 pandemic in England, UK

    Assessing how the COVID-19 pandemic impacted incidence and quality of care for people with gout in England, UK.

    Status: Published

    Categories

    • OpenSAFELY
  33. Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway

    The pandemic affected healthcare in England across the pancreatic cancer pathway. Positive lessons could be learnt from the services that were resilient and those that recovered quickly

    Status: Published

    Categories

    • OpenSAFELY
  34. Living alone and mental health: parallel analyses in UK longitudinal population surveys and electronic health records prior to and during the COVID-19 pandemic

    People living alone have poorer mental health and lower life satisfaction. During the pandemic, this gap in self-reported distress remained; however, there was a narrowing of the gap in service use.

    Status: Published

    Categories

    • OpenSAFELY
  35. Impact of COVID-19 on recorded blood pressure screening and hypertension management in England

    We describe the impact of the COVID-19 pandemic on blood pressure screening and hypertension management.

    Status: Preprint

    Categories

    • OpenSAFELY
  36. Eleven key measures for monitoring general practice clinical activity during COVID-19

    This paper presents an important effort to develop an open-source software framework for monitoring trends and variations in healthcare over time in England. They demonstrate a compelling example of how this system can track key healthcare indicators over the course of the COVID-19 pandemic.

    Status: Published

    Categories

    • OpenSAFELY
  37. Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections

    We studied the changes in hospital admission rates for common infections during the Covid-19 pandemic, for those having and having not received antibiotic prescriptions in primary care

    Status: Preprint

    Categories

    • OpenSAFELY
  38. Repeated antibiotic exposure and risk of hospitalisation and death following COVID-19 infection

    We examined whether prior frequent antibiotic exposure is associated with severe COVID-19 outcomes.

    Status: Published

    Categories

    • OpenSAFELY
  39. Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England

    We aimed to describe the impact of pandemic-related disruption on ethnic differences in clinical monitoring and hospital admissions for non-COVID conditions in England.

    Status: Published

    Categories

    • OpenSAFELY
  40. Patient Characteristics Associated with Repeat Antibiotic Prescribing Pre- and during the COVID-19 Pandemic

    With the approval of NHS England, we conducted a retrospective cohort study of >19 million English primary care patient records using the OpenSAFELY-TPP analytics platform. We analysed repeat/non-repeat prescribing frequency in monthly patient cohorts between January 2020 and 2022.

    Status: Published

    Categories

    • OpenSAFELY
  41. A National Audit of Pancreatic Enzyme Prescribing in Pancreatic Cancer from 2015 to 2023 in England

    Investigating the impact of the COVID-19 pandemic on PERT prescribing to people with unresectable pancreatic cancer and to investigate the national and regional rates from January 2015 to January 2023.

    Status: Published

    Categories

    • OpenSAFELY
  42. Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY

    This study aimed to implement complex, PINCER (pharmacist led information technology intervention) prescribing indicators, on a national scale with general practice data to describe the impact of the covid-19 pandemic on safe prescribing.

    Status: Published

    Categories

    • OpenSAFELY
  43. Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages

    We used the OpenSAFELY platform to emulate target trials to estimate the effectiveness of sotrovimab or molnupiravir, versus no treatment.

    Status: Preprint

    Categories

    • OpenSAFELY
  44. Impact of COVID-19 on broad-spectrum antibiotic prescribing for common infections in primary care in England

    The COVID-19 pandemic impacted the healthcare systems, adding extra pressure to reduce antimicrobial resistance. Therefore, we aimed to evaluate changes in antibiotic prescription patterns after COVID-19 started.

    Status: Published

    Categories

    • OpenSAFELY
  45. The impact of COVID-19 on antibiotic prescribing in primary care in England

    This study predicted risk factors for potentially inappropriate prescribing in primary care and how this changed during the Covid-19 pandemic

    Status: Published

    Categories

    • OpenSAFELY
  46. Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data

    This paper discusses the challenges in estimating vaccine effectiveness using observational data, and describes two approaches that help to overcome these challenges.

    Status: Published

    Categories

    • OpenSAFELY
  47. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022

    This study aimed to describe the burden of COVID-19-related mortality in population subgroups and how this has changed over successive waves of the pandemic, and report trends in absolute and relative COVID-19-related mortality risks across clinical and demographic population subgroups from 2020 to 2022.

    Status: Published

    Categories

    • OpenSAFELY
  48. Deaths at home during the Covid-19 pandemic and implications for patients and services

    A comparison of the services used by people who died at home in England in the first year of the pandemic to the year prior to the pandemic, exploring indicators of quality of care, and looking at differences between sociodemographic groups.

    Status: Published

    Categories

    • OpenSAFELY
  49. Postoperative mortality and complications in patients with and without pre-operative SARS-CoV-2 infection

    We adapted the COVIDSurg protocol for a service evaluation of surgical procedures that took place within the English NHS from 17 March 2018 to 17 March 2022.

    Status: Published

    Categories

    • OpenSAFELY
  50. Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England

    A comparison of the Pfizer and Moderna vaccines for protecting against Covid-19 during the first booster programme in England

    Status: Published

    Categories

    • OpenSAFELY
  51. First dose COVID-19 vaccine coverage amongst adolescents and children in England

    Describing trends and variation in first dose COVID vaccine coverage in different clinical and demographic groups amongst adolescents and children in England

    Status: Published

    Categories

    • OpenSAFELY
  52. Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings

    This paper aims to develop a framework for detailed near real-time monitoring of treatment deployment, to ascertain eligibility status for patients and to describe trends and variation in coverage of treatment between geographic, clinical and demographic groups.

    Status: Published

    Categories

    • OpenSAFELY
  53. OpenSAFELY NHS Service Restoration Observatory 2

    We describe changes in the volume and variation of coded clinical activity in general practice in: (i) cardiovascular disease, (ii) diabetes, (iii) mental health, (iv) female and reproductive health, (v) screening, and (vi) processes related to medication.

    Status: Published

    Categories

    • OpenSAFELY
  54. Factors associated with COVID-19 vaccine uptake in people with kidney disease

    We describe COVID-19 vaccine coverage among people with moderate-to-severe kidney disease in England up to 31 August 2022, and characterise individual-level factors associated with delayed vaccine uptake.

    Status: Published

    Categories

    • OpenSAFELY
  55. Primary care coding activity related to the use of online consultation systems or remote consulting

    We explore general practice coding activity associated with the use of online consultation systems in terms of trends, COVID-19 effect, variation and quality.

    Status: Preprint

    Categories

    • OpenSAFELY
  56. Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease

    We compared the risk of COVID-19 among people with moderate-severe kidney disease who received different combinations of Astrazeneca and Pfizer–BioNTech COVID-19 vaccine over the course of the pandemic

    Status: Preprint

    Categories

    • OpenSAFELY
  57. Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community

    Comparing the effectiveness of sotrovimab (a neutralising monoclonal antibody) with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients infected with SARS-CoV-2 in the community and at high risk of severe outcomes from covid-19.

    Status: Published

    Categories

    • OpenSAFELY
  58. Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic

    We used OpenSAFELY to replicate key metrics from the National Early Inflammatory Arthritis Audit (NEIAA), and to assess the impact of COVID-19 on the delivery of care for people with autoimmune inflammatory arthritis in England.

    Status: Published

    Categories

    • OpenSAFELY
  59. Recording of ‘COVID-19 vaccine declined’

    A description of the patterns of usage of codes for COVID-19 vaccines being declined.

    Status: Published

    Categories

    • OpenSAFELY
  60. Association between household composition and severe COVID-19 outcomes in older people by ethnicity

    This paper aims to quantify the association between household composition and risk of severe COVID-19 by ethnicity for older individuals

    Status: Published

    Categories

    • OpenSAFELY
  61. Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose

    A cohort study to assess the extent of waning of effectiveness following a second dose of BNT162b2 and ChAdOx1 covid-19 vaccines

    Status: Published

    Categories

    • OpenSAFELY
  62. Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England

    A compararison of the effectiveness of the BNT162b2 mRNA (Pfizer-BioNTech) and the ChAdOx1 (Oxford-AstraZeneca) COVID-19 vaccines against infection and COVID-19 disease in health and social care workers.

    Status: Published

    Categories

    • OpenSAFELY
  63. Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England

    This paper investigates the representativeness of OpenSAFELY-TPP data by comparing it to national population estimates.

    Status: Published

    Categories

    • OpenSAFELY
  64. Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England

    This paper describes the characters of individuals who have experienced COVID-19 vaccine breakthrough after their second vaccination.

    Status: Published

    Categories

    • OpenSAFELY
  65. Association between oral anticoagulants and COVID-19-related outcomes

    This paper investigates the association between OACs and COVID-19 outcomes in those with atrial fibrillation and a CHA2DS2-VASc score of 2.

    Status: Published

    Categories

    • OpenSAFELY
  66. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records

    This paper combines results from longitudinal cohort studies with electronic health data from OpenSAFELY, to describe how risk of long COVID varies amongst demographic and clinical factors.

    Status: Published

    Categories

    • OpenSAFELY
  67. Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies

    This paper aimed to assess the risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and in those on immune-modifying therapies.

    Status: Published

    Categories

    • OpenSAFELY
  68. Effectiveness of BNT162b2 booster doses in England

    We estimate the effectiveness of boosting with BNT162b2 compared with no boosting in eligible adults who had received two primary course vaccine doses in England.

    Status: Preprint

    Categories

    • OpenSAFELY
  69. Safety of COVID-19 vaccination and acute neurological events

    This paper investigates the potential association of COVID-19 vaccination with three acute neurological events: Guillain-Barré syndrome (GBS), transverse myelitis and Bell’s palsy.

    Status: Published

    Categories

    • OpenSAFELY
  70. Impact of First UK COVID-19 Lockdown on Hospital Admissions

    This study used OpenSAFELY (on behalf of NHS England), EAVEII (Scotland) and SAIL Databank (Wales) to investigate the weekly hospital admission rates for cancer, cardiovascular and respiratory conditions (excluding COVID-19) broken down by disease, sex, socioeconomic group and ethnicity group in a federated analysis across England, Scotland and Wales.

    Status: Published

    Categories

    • OpenSAFELY
  71. Accident and emergency (AE) attendance in England following infection with SARS-CoV-2 Omicron or Delta

    We estimate the risk of accident and emergency (AE) attendance following confirmation of SARS-CoV-2 infection in England, comparing infection with Omicron to Delta

    Status: Preprint

    Categories

    • OpenSAFELY
  72. Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England

    Patients with COVID-19 are thought to be at higher risk of cardiometabolic and pulmonary complications, but quantification of that risk is limited. Working on behalf of NHS England, this study aimed to describe the overall burden of these complications in survivors of severe COVID-19 using OpenSAFELY.

    Status: Published

    Categories

    • OpenSAFELY
  73. Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform

    This paper evaluate different methods for predicting COVID-19-related death using the OpenSAFELY platform

    Status: Published

    Categories

    • OpenSAFELY
  74. Potentially inappropriate prescribing of DOACs to people with mechanical heart valves

    We conducted a retrospective cohort study of DOAC prescribing in people with a record of a mechanical heart valve between September 2019 and May 2021, and describe the characteristics of this population.

    Status: Published

    Categories

    • OpenSAFELY
  75. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation

    This paper investigates whether risks of hospital admission and death, overall and by specific cause, are raised following discharge from a COVID-19 hospitalisation.

    Status: Published

    Categories

    • OpenSAFELY
  76. Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic

    This paper describe trends in the mortality risk among residents of care homes compared to private homes during the first and second waves of the COVID-19 pandemic in England.

    Status: Published

    Categories

    • OpenSAFELY
  77. OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19

    Working on behalf of NHS England, this study used the OpenSAFELY platform to describe the volume and variation of coded clinical activity in general practice between January 2019 and September 2020, taking respiratory disease and laboratory procedures as examples.

    Status: Published

    Categories

    • OpenSAFELY
  78. Trends and clinical characteristics of COVID-19 vaccine recipients

    Vaccine coverage and time trends across a range of demographic and fine-grained clinical subgroups in eight Joint Committee on Vaccination and Immunisation (JCVI) priority cohorts.

    Status: Published

    Categories

    • OpenSAFELY
  79. Impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic

    This paper describes which people were switched from warfarin to DOACs during the COVID-19 pandemic following an update in national guidance

    Status: Published

    Categories

    • OpenSAFELY
  80. Clinical coding of long COVID in English primary care

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to measure the proportion of people with a recorded code for long COVID, overall and by demographic factors, electronic health record software system, and week.

    Status: Published

    Categories

    • OpenSAFELY
  81. Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants

    This paper conducted a population-based cohort study investigating the association between warfarin and COVID-19 outcomes compared with direct oral anticoagulants (DOACs).

    Status: Published

    Categories

    • OpenSAFELY
  82. Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England

    This paper aims to describe the severity of the alpha variant in terms of the pathway of disease from testing positive to hospital admission and death.

    Status: Published

    Categories

    • OpenSAFELY
  83. Risks of covid-19 hospital admission and death for people with learning disability

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to assess the association between learning disability and risk of hospitalisation and mortality from COVID-19 in England among adults and children.

    Status: Published

    Categories

    • OpenSAFELY
  84. Factors associated with deaths due to COVID-19 versus other causes

    We aimed to investigate how specific factors are differentially associated with COVID-19 mortality as compared to mortality from causes other than COVID-19.

    Status: Published

    Categories

    • OpenSAFELY
  85. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the COVID-19 pandemic in England.

    Status: Published

    Categories

    • OpenSAFELY
  86. Identifying Care Home Residents in Electronic Health Records

    This short data report describes the partial overlap between three methods for identifying care home residents in EHR, and provides detailed instructions for how to implement these in OpenSAFELY-TPP to support research into the impact of the COVID-19 pandemic on care home residents.

    Status: Published

    Categories

    • OpenSAFELY
  87. Association between living with children and outcomes from covid-19

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to investigate whether risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and outcomes of coronavirus disease 2019 (covid-19) differed between adults living with and without children during the first two waves of the UK pandemic.

    Status: Published

    Categories

    • OpenSAFELY
  88. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7

    Working on behalf of NHS England, this paper uses the OpenSAFELY platform to estimate the risk of death following confirmation of SARS-CoV-2 infection in England, comparing infection with VOC to non-VOC, after accounting for demographic factors and comorbidities

    Status: Published

    Categories

    • OpenSAFELY
  89. Changes in the rate of cardiometabolic and pulmonary events during the COVID-19 pandemic

    Working on behalf of NHS England, this study used the OpenSAFELY platform to describe the overall rate of various key clinical events over time, and their relationship with COVID-19.

    Status: Preprint

    Categories

    • OpenSAFELY
  90. Short report: Ethnicity and COVID-19 death in the early part of the COVID-19 second wave in England

    This short data report investigates whether there were ethic inequalities in COVID-19 death in the second wave in England.

    Status: Preprint

    Categories

    • OpenSAFELY
  91. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to assess the association between routinely prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and deaths from COVID-19.

    Status: Published

    Categories

    • OpenSAFELY
  92. HIV infection and COVID-19 death

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to investigate the association between HIV infection and COVID-19 mortality.

    Status: Published

    Categories

    • OpenSAFELY
  93. Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to investigate the effectiveness of hydroxychloroquine for prevention, as opposed to treatment, of COVID-19 mortality. We found no evidence of benefit or harm after adjusting for important differences between people with the same health conditions prescribed hydroxychloroquine or not.

    Status: Published

    Categories

    • OpenSAFELY
  94. Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform

    This protocol reports details of a planned study to explore the extent to which incorporating time-varying measures of infection burden over time improves the quality of risk prediction models for COVID-19 death in a large population of adult patients in England.

    Status: Preprint

    Categories

    • OpenSAFELY
  95. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to investigate the association between ICS and COVID-19-related death among people with COPD or asthma using linked electronic health records (EHRs) in England, UK.

    Status: Published

    Categories

    • OpenSAFELY
  96. Factors associated with COVID-19-related death using OpenSAFELY

    Working on behalf of NHS England, this paper used the OpenSAFELY platform to quantify a range of clinical risk factors for COVID-19-related death in the largest cohort study conducted by any country to date.

    Status: Published

    Categories

    • OpenSAFELY
  97. Better use of data and digital offer rapid opportunities to address covid-19

    COVID-19 digital and data BMJ Blog

    Categories

    • Open Working
    • OpenPathology
    • OpenSAFELY
    • Policy Insights